|
|
||||||||
1 Mount Desert Island Biological Laboratory, Salisbury Cove, Maine 04672; 2 Department of Environmental Medicine, University of Rochester, Rochester, New York 14642; 3 Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709; and 4 Department of Physiology and Neurobiology, University of Connecticut-Storrs, Storrs, Connecticut 06269
| |
ABSTRACT |
|---|
|
|
|---|
Spiny dogfish shark (Squalus acanthias) lateral and IV choroid plexuses (CPs) are ultrastructurally similar to the corresponding tissues of rat. However, shark IV CP is proportionally larger and easily accessible. Moreover, this epithelial sheet can be halved and studied in Ussing flux chambers. We have used confocal fluorescence microscopy and radiotracer techniques to characterize transepithelial transport of the organic anions (OAs) fluorescein (FL) and 2,4-dichlorophenoxyacetic acid (2,4-D), respectively, by shark CP. Lateral and IV CP accumulated 1 µM FL, with highest levels in the underlying extracellular spaces, intermediate levels in epithelial cells, and lowest levels in the medium. 2,4-D and probenecid inhibited FL accumulation in cells and extracellular spaces, suggesting that these substrates compete for common carriers. Unidirectional absorptive [cerebrospinal fluid (CSF)-to-blood] and secretory (blood-to-CSF) fluxes of 10 µM [14C]2,4-D were measured under short-circuited conditions in IV CP mounted in Ussing chambers. 2,4-D underwent net absorption, with an average flux ratio of 7. Probenecid, 2,4,5-trichlorophenoxyacetic acid, and 5-hydroxyindolacetic acid reduced net absorption, reversibly inhibiting unidirectional absorption, with no effect on secretion. Ouabain irreversibly reduced net 2,4-D absorption and cellular and extracellular accumulation of FL, suggesting energetic coupling of OA absorption to Na+ transport. Collectively, these data indicate that shark CP actively removes OAs from CSF by a process that is specific and active.
blood-cerebrospinal fluid barrier; xenobiotic; 2,4-dichlorophenoxyacetic acid; dogfish; elasmobranch
| |
INTRODUCTION |
|---|
|
|
|---|
THE NEURONS AND GLIA of the central nervous system (CNS) are particularly sensitive to chemical injury and require a narrowly regulated extracellular fluid (ECF) compartment. Two main barriers separate the brain's ECF from blood: the blood-brain barrier (BBB) formed by the endothelium of the cerebral capillaries and the blood-cerebrospinal fluid (CSF) barrier in the choroid plexus (CP). More than just passive partitions, these barriers possess specific transporters that selectively mediate the exchange of various organic substrates between plasma and brain intercellular space fluid and CSF. Together, the BBB and CP not only protect the CNS by actively removing xenobiotics and endogenous metabolites from brain ECF but also limit access of therapeutic agents to the brain, minimizing their efficacy. Thus the BBB and blood-CSF barrier play important roles in regulating the composition of the extracellular environment of brain cells under physiological and toxicological conditions (3, 4, 25, 26, 31). Although these barriers are potentially critical points in the regulation of brain ECF composition, we lack a detailed understanding of the mechanisms that mediate and modulate organic ion transport.
It has been known for 40 years that potent excretory transport systems
in the choroidal epithelium remove excess organic anions (OAs) and
other organic compounds from the brain (16, 18, 22). Thus
CP has been called the "kidney of the brain" (26). On
the basis of in vivo clearance and in vitro tissue accumulation studies
conducted predominantly in mammals, OAs removed from the brain by CP
include xenobiotics, e.g., 2,4-dichlorophenoxyacetic acid
(2,4-D) (12), drugs and their metabolites,
e.g., penicillin (7, 27, 28) and salicylic acid
(14), and neurotransmitter metabolites, e.g.,
5-hydroxyindoleacetic acid (5-HIAA) (5, 8, 19) and
homovanillic acid (13). Ventriculocisternal perfusion,
microdialysis, and tissue accumulation studies have indicated that a
broadly specific, probenecid-sensitive transport system in CP, probably
active, removes OAs from CSF (10, 20). Recent work on
ventricular membranes and isolated segments of mammalian CP
(21) showed that the initial uptake of OAs,
e.g., 2,4-D, from CSF is mediated by an OA transporter-1
(OAT1), a tertiary active
-ketoglutarate (
-KG)/OA exchange
mechanism coupled to Na+-K+-ATPase via
Na+-driven Na+-dicarboxylate cotransport. This
transporter is functionally identical to the OAT1 characterized in
renal proximal tubule basolateral membranes (29). The
mechanism(s) for basolateral efflux into the blood compartment remains
unclear, although recent confocal imaging studies with isolated rat CP
suggest rheogenic, facilitated efflux of OAs from the epithelial cell
to the perivascular-vascular compartment (1).
Direct experimental characterization of the cellular mechanisms that mediate and modulate transepithelial transport of OAs and other solutes across an intact mammalian blood-CSF barrier has been hindered by a combination of factors, including complex morphology, relatively small size, and limited accessibility. Indeed, immediate access to the blood side or basolateral pole of the mammalian choroidal epithelium is especially limited, if not restricted altogether, when techniques such as ventriculocisternal perfusion and isolated vascularly perfused CP are used. The objective of the present study was to establish the CP of the spiny dogfish shark as an alternative model for direct and quantitative measurement of transepithelial flux of OAs across an intact, native blood-CSF barrier. The morphology and ultrastructure of shark and rat CP are strikingly similar. Confocal fluorescence microscopic imaging showed that shark lateral and IV CP accumulated fluorescein (FL) in a manner similar to mammalian CP. The IV CP of the shark, however, is a large epithelial monolayer, mountable in Ussing flux chambers, such that unidirectional absorption and secretion of [14C]2,4-D can be directly measured in the absence of transepithelial chemical or electrical gradients. In the present study, net active transepithelial absorption of 2,4-D was unequivocally demonstrated.
| |
METHODS AND MATERIALS |
|---|
|
|
|---|
Animals. Adult male and female spiny dogfish sharks (Squalus acanthias, ~2 kg body wt) were collected from the coastal waters of Mount Desert Island, ME, and held in large (3-m-diameter) tanks of flowing sea water 1-4 days before use. Animals were decapitated, and the cranial compartment was immediately removed, flooded with ice-cold elasmobranch Ringer (ER) solution (in mM: 280 NaCl, 6 KCl, 4 CaCl2, 3 MgCl2, 1 NaH2PO4, 0.5 Na2SO4, 350 urea, 72 trimethylamine oxide, 2.5 glucose, and 8 NaHCO3, pH 7.8), and placed on ice. The brain was removed and immersed in ice-cold ER solution. The lateral (anterior) and IV CPs were dissected and cleared of extraneous neural and connective tissue.
Chemicals. FL was purchased from Molecular Probes (Eugene, OR), unlabeled 2,4-D, probenecid, 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), 5-HIAA, and ouabain from Sigma-Aldrich (St. Louis, MO), and [14C]2,4-D (50 mCi/mmol) from American Radiolabeled Chemical (St. Louis, MO). All other chemicals were of the highest grade and were obtained from commercial vendors.
Electron microscopy. Freshly harvested shark lateral (~10 mg wet wt) and IV CPs (~60 mg wet wt) were fixed with 1.5% glutaraldehyde and 1.5% formaldehyde in a high-sucrose-cacodylate buffer (150 mM sodium cacodylate, 3 mM MgCl2, and 20% sucrose, pH 7.4) on ice for 2 h. After several rinses in chilled buffer, tissues were stored overnight at 4°C, postfixed with 1% glutaraldehyde and 2% osmium tetroxide, and then further processed for scanning or transmission electron microscopy. Rat lateral CP was treated identically; however, the fixative contained 100 mM phosphate buffer (pH 7.5) and no cacodylate or sucrose. For scanning electron microscopy, tissues were dehydrated through an ethanol series, critical point dried with 100% ethanol as the transition fluid, sputter coated with gold, and examined on a field-emission scanning electron microscope (model HPS50, Coates and Welter). For transmission electron microscopy, tissues were also dehydrated in a graded ethanol series and propylene oxide and then embedded in a mixture of Epon 812 and Araldite. Thin sections were observed with a electron microscope (model 300, Phillips) operating at 80 kV.
Confocal fluorescence microscopy. To examine FL accumulation, three to four segments (~3-5 mm2) were cut from each lateral or IV CP. Segments were incubated individually in covered Teflon chambers containing 1 µM FL in 1.0 ml of ER solution. Each chamber had a glass coverslip bottom, through which the tissue could be viewed on an inverted microscope. Various test compounds were added to the incubation medium as stock solutions in ER solution or dimethylsulfoxide. The dimethylsulfoxide concentration in the medium did not exceed 0.5%, and preliminary experiments indicated that this concentration of solvent had no effect on FL transport in shark CP. All experiments were conducted at room temperature (18-20°C).
To acquire images, chambers containing CP segments were placed on an inverted confocal microscope (Zeiss model 510 or Olympus Fluoview) and viewed through transmitted light illumination. An area including undamaged epithelium and underlying blood vessel was selected, and a confocal fluorescence image (four 512 × 512 × 8 bit frames averaged) and the corresponding transmitted light image were acquired and saved to a disk. Images were acquired using a ×63 (Zeiss) or ×40 (Olympus) water immersion objective (NA 1.2), the 488-nm line of an argon ion laser, a 505-nm dichroic filter, and a 510-nm long-pass emission filter. The photomultiplier gain was set to give an average cellular fluorescence intensity of 50-100 (full scale = 255), and tissue autofluorescence was undetectable. Fluorescence intensities were measured from stored images using Zeiss Image Analyzer software or Scion Image software, as described previously (1). For each control and experimental condition, 5-10 areas of epithelium and adjacent vasculature were selected for measurement. The average pixel intensity for each area was measured, and background fluorescence intensity was subtracted. Although some preparation-to-preparation variation in transport ability was noted, most of the differences in fluorescence intensities for control tissue reflect changes in photomultiplier gain settings. Data are results of single experiments that are representative of two to four experiments. In a simple aqueous solution, such as ER solution, the relationship between fluorescence intensity and FL concentration was linear for nearly the entire eight-bit range of the confocal microscopes. However, because there are uncertainties in relating cellular fluorescence to the actual concentration of an accumulated compound in cells and tissues with complex geometry, data are reported here as average measured pixel intensity, rather than estimated dye concentration.Ussing chamber studies. Transepithelial transport and electrophysiological properties of IV CP were determined in Ussing flux chambers. A single freshly isolated IV CP was divided in half. Each half was transferred to a piece of Nitex (150-µm mesh) and mounted in an Ussing chamber; filter paper O rings and silicone grease were placed on the CSF and blood surfaces to prevent slippage and leakage, respectively. Aperture size was 0.32 cm2. Each hemichamber was filled (1.9 ml) with ER solution (pH 7.8) containing 10 µM 2,4-D, continually gassed with humidified 99% O2-1% CO2, and vigorously stirred to minimize unstirred layers. Chamber temperature was maintained at 19°C (live animal holding tanks varied from 13°C to 19°C over the summer months).
Flux chambers were attached to an automatic dual-voltage clamp (model EC4000-2, WPI, Sarasota, FL) interfaced with a computer-controlled acquisition board (MacLab, ADI Instruments, Grand Junction, CO). Transepithelial potential difference (PD), transepithelial resistance (TER), and short-circuit current (ISC) were measured under control and experimental conditions to assess the fundamental physical and functional integrity of the epithelium. PD was determined (±0.1 mV) for each half-plexus with a pair of reference Ag/AgCl electrodes connected to the CSF and blood compartments by 3 M KCl-2% agar bridges (PE-90 tubing). Current was passed through a second set of Ag/AgCl electrodes connected to the CSF and blood compartments by 3 M KCl-2% agar bridges. TER was determined by measuring the change in PD produced in response to a brief 10-µA current pulse; corrections were made to account for the presence of Nitex and Ringer solution. PD and TER were measured in paired halves of individual IV CPs from 46 animals. Under control conditions, the mean PD was +1.21 ± 0.05 (SE) mV (CSF-side positive); no PD was detected after tissues were scraped off the supporting Nitex. The mean TER was 73.15 ± 3.51 (SE)
· cm2. The
transepithelial flux of 2,4-D by IV CP was examined under chemical and
electrical short-circuit conditions, i.e., ER solution on
both sides and transepithelial PD clamped at 0 mV, and the mean
Isc was
2.38 ± 0.13 (SE)
µA/cm2 (n = 46). Under control
conditions, transepithelial PD, TER, and Isc
remained stable for
4 h.
The unidirectional absorptive and secretory fluxes of 10 µM 2,4-D,
i.e., CSF-to-blood flux and blood-to-CSF flux, respectively, were initiated by addition of 1 µCi of [14C]2,4-D to
the CSF side or blood side of each half-plexus. Duplicate 50-µl
samples were taken from the unlabeled hemichamber every 30 min and
replaced with an equal volume of Ringer solution containing 10 µM
2,4-D. Duplicate 10-µl samples were taken from the labeled hemichamber at the beginning and end of the flux period. Radioactivity was determined by liquid scintillation with quench correction (Tri-Carb
2100, Hewlett-Packard, Meriden, CT). The net transepithelial flux of
2,4-D by a single IV CP was calculated by subtracting the blood-to-CSF
(secretory) flux from the CSF-to-blood (absorptive) flux measured in
its respective paired half. Experiments were conducted on single IV CPs
harvested from a minimum of three animals.
Statistics.
Values are means ± SE. For FL accumulation experiments, control
and experimental means were compared by one-way analysis of variance
followed by a Dunnett's post hoc test. For 2,4-D transepithelial flux
experiments, control and experimental 60-min flux rates were compared
by one-tailed Student's paired t-test. Differences were deemed significant at P
0.05.
| |
RESULTS |
|---|
|
|
|---|
Comparative morphology of CP.
The morphology and ultrastructure of the dogfish shark IV CP and rat
lateral CP were compared using scanning and transmission electron
microscopy and appeared remarkably similar (Fig.
1). As seen by transmission electron
microscopy (Fig. 1, A-C), in both species a monolayer
of epithelial cells containing numerous mitochondria interfaces in vivo
with the CSF within the ventricular compartment. Tight junctions
(zonula occludens) between the epithelial cells separate the apical
(ventricular) and basolateral membranes (Fig. 1C).
Furthermore, the capillaries in the stroma beneath the
epithelium are fenestrated, and thus the blood (plasma)
compartment of the CP is functionally contiguous with the interstitial
fluid bathing the epithelial basolateral (or blood-facing) membrane. Therefore, the epithelial tight junctions separate the CSF compartment from the blood compartment to form the actual blood-CSF barrier (Fig.
1C; also see Fig. 3A).
|
Transepithelial transport of OAs by shark CP.
Previous studies had demonstrated that mammalian lateral CP avidly
accumulated the fluorescent OA, FL (1, 2). Figure 2, A and B, shows
respective transmitted light and confocal fluorescence images of a
segment of shark lateral CP after 30 min of incubation with 1 µM FL
in ER solution. The epithelial monolayer and vascular compartment were
clearly distinguishable in transmitted light (Fig. 2A).
Because of the high density of microvilli at the surface of the
ventricular membrane, these structures collectively appeared as a
refractile element at the interface of the epithelium and the medium.
The intercellular spaces at the basolateral or blood side of the
epithelium were also visible. The confocal micrograph shows FL
accumulation within the tissue (Fig. 2B). FL distribution was not uniform. Fluorescence intensity was lowest in the medium, higher in the epithelial cells, and highest in the basolateral and
perivascular spaces [extracellular spaces (ECS); Fig. 2B]. Even at this relatively low magnification, the region of highest fluorescence intensity filled and acutely defined an area that included
basolateral intercellular spaces and the blood vessels. This
observation was consistent with free exchange of fluid and solute
between the interstitium and vascular compartment through fenestrated capillaries. At higher magnification, it was evident that this region of high fluorescence extended from the base of the
epithelial cells to the tight junctions that separate the ECS from the
medium (Figs. 2C and
3A).
|
|
2 · h
1, the
secretory flux was 0.10 ± 0.02 nmol · cm
2 · h
1, and the
net CSF-to-blood flux was 0.63 ± 0.12 nmol · cm
2 · h
1
(n = 3). The average 60-min flux ratio was ~7. The
electrical properties of the tissue remained stable over the 3-h flux
period.
|
|
|
-KG/OA exchange
(OAT1) that is indirectly coupled to Na+-driven reuptake of
the tricarboxylic acid cycle intermediate (21). On the
basis of the mammalian model, OA transport and accumulation by shark
plexus should decrease if the Na+ gradient at the
ventricular membrane is reduced. Treatment of shark IV CP with 250 µM
ouabain, an inhibitor of Na+-K+-ATPase, reduced
net transepithelial absorption of 2,4-D by >75% (Fig. 5B).
This was due to a large decrease in the unidirectional absorptive flux
(1.13 ± 0.49 vs. 0.42 ± 0.22 nmol · cm
2 · h
1,
P < 0.04) without a decrease in secretory (leak) flux
(P > 0.14; Fig. 5B). Although TER did not
change with ouabain treatment, within 30 min the transepithelial PD was
reduced from 1.2 to 0.2 mV and ISC was
essentially eliminated (Table 1). Ouabain-induced changes in transport
and electrical parameters were not reversed after the tissue was
rinsed. In agreement with these data, confocal imaging showed that
ouabain also reduced FL accumulation in the cellular and ECS
compartments of lateral CP (Fig. 5B). The imaging data
clearly demonstrated that ouabain reduced transport at the apical
membrane of the epithelial cells. However, it was not clear from these
data whether the basolateral step was also affected.
At 100 µM, a second anionic herbicide, 2,4,5-T, and the serotonin
metabolite 5-HIAA each inhibited 2,4-D transport. 2,4,5-T reduced
unidirectional 2,4-D absorption on average 60% (from 0.50 ± 0.18 to 0.21 ± 0.10 nmol · cm
2 · h
1) with no
significant effect on secretory flux (P > 0.07; Fig. 6A). As a result, net
transport was abolished. 5-HIAA also reduced net absorption of 2,4-D
(Fig. 6B). Here again, the unidirectional absorption was
reduced (from 0.84 ± 0.23 to 0.45 ± 0.15 nmol · cm
2 · h
1,
P < 0.03), while the secretory leak flux did not
change (P > 0.3). Inhibition of 2,4-D transport by
2,4,5-T and 5-HIAA was reversible; within 1 h of their removal,
net and unidirectional fluxes of 2,4-D returned to control steady-state
values. Neither compound affected the tissue's electrical parameters
(Table 1).
|
| |
DISCUSSION |
|---|
|
|
|---|
The CP is a highly vascularized, electrically leaky epithelium that comprises the blood-CSF barrier. It produces CSF and facilitates selective exchange of OAs and other solutes between the blood and the brain's ECF (3). Thus the CP is an important determinant of the extracellular environment of the cells within the CNS, regulating levels of essential nutrients and modulators and removing potentially toxic waste products of metabolism and xenobiotics. In vivo and in vitro techniques have demonstrated that, by a specific and concentrative transport mechanism, the CP removes OAs from the CSF, transporting them to the blood for eventual excretion by the liver and kidney (10, 20). However, the complex morphology, small size, and anatomic location of mammalian CP have made characterization of cellular and molecular mechanisms of fluid and solute transport across the intact blood-CSF barrier difficult.
In the present study, we have taken advantage of the favorable
neuroanatomy of a comparative model, the spiny dogfish shark, to
overcome the methodological limitations presented by mammalian models.
The morphology and ultrastructure of the shark CP were strikingly
similar to those of the rat (Fig. 1); however, the most overt anatomic
differences were the size and accessibility, particularly those of the
IV CP. In both species, the IV CP is a single epithelial cell layer
that forms the roof of the IV ventricle. However, whereas the IV CP of
the adult rat is small (~10 × 2 mm) and tucked between the
cerebellum and medulla, the IV CP of the shark is proportionally larger
(~15 × 25 mm) and lays unobstructed over the IV ventricle in
the medulla. Shark IV CP was large enough such that paired halves could
be mounted in Ussing chambers. In this apparatus, as in situ, the
single epithelial sheet of the IV CP physically separates the CSF and
blood compartments, given that the capillaries of this tissue are
fenestrated. Each compartment could be discretely sampled, and the
tissue's bioelectrical properties could be monitored and manipulated.
Thus unidirectional absorptive and secretory fluxes of substrate were
directly measured under biophysically precise conditions. The
electrical properties for IV CP determined in this study were
comparable to those previously reported for dogfish shark IV plexus and
frog posterior plexus mounted in flux chambers (6, 17).
Finally, the tissue maintained its functional and physical polarity for
an extended period (
4 h).
Using two methods, we have begun to characterize OA transport across intact shark CP. First, we used confocal microscopy to visualize the transport of the fluorescent OA, FL, from bath to epithelial cell to ECS in lateral and IV CP. Second, unidirectional fluxes of [14C]2,4-D were measured in the absence of transepithelial chemical and electrical gradients in IV CP mounted in flux chambers. Confocal images of lateral and IV CP showed concentrative uptake of FL at the apical membrane of the epithelium and further concentration of this OA within the underlying interstitial spaces and blood vessels (Fig. 2). This two-step pattern of transport was not only identical to that recently reported for FL in intact rat lateral CP (1) but was, moreover, consistent with the concentrative absorption of FL from CSF. Furthermore, active transepithelial absorption of 2,4-D was unequivocally demonstrated. When unidirectional transepithelial fluxes were measured under short-circuited conditions in IV CP mounted in flux chambers, a large net absorptive flux was determined (flux ratio = 4-7; Fig. 4A). These data for shark CP are consistent with ventriculocisternal perfusion studies in mammals, which have shown clearance of OAs, such as 2,4-D, from CSF (11, 16) and concentrative, mediated accumulation of a variety of OAs by isolated CP in vitro (for review see Ref. 20).
On the basis of previous in vivo and in vitro studies on mammals, a variety of OAs may be cleared from the CSF and accumulated by the CP by a specific OA carrier-mediated system. In addition to the prototypic OA transport inhibitor probenecid, the anionic metabolites of dopamine and serotonin and other xenobiotics have been shown to interact with the OA transport system of CP (12, 13). The inhibitory effects of various agents on OA transport by shark CP further support the physiological significance of CP in homeostatic regulation of the brain's ECF compartment. As in the rat, the OAs 2,4-D and probenecid inhibited FL accumulation by shark lateral CP, attenuating cellular and ECS fluorescence. At a minimum, this indicated inhibition of a specific OA carrier at the apical (CSF) side of the tissue. However, transepithelial 2,4-D transport by shark IV CP in flux chambers was also inhibited by probenecid and other substrates of the mammalian choroidal OA transport system, 2,4,5-T and 5-HIAA (Figs. 5A and 6). By this method, it was clearly evident that unidirectional absorption, not secretion, was specifically abolished by these agents. Furthermore, in each case, inhibition was reversed on removal of inhibitor, and the electrical characteristics of the tissue were not affected. Thus we conclude that one or more OA transporters mediate unidirectional absorption and that 2,4-D may share a common carrier with FL, 2,4,5-T, and 5-HIAA.
In the simplest model of active OA transport across the CP epithelium,
initial uptake of OAs from CSF at the apical membrane is active
(i.e., against chemical and electrical gradients) and efflux
at the basolateral membrane is passive, driven by membrane potential
(1). Recent studies on isolated membranes and segments of
mammalian plexus suggest that apical uptake of OAs is mediated by
-KG/OA exchange, i.e., OAT1, coupled to
Na+-driven Na+-dicarboxylate cotransport, as in
renal proximal tubule (1, 21). These studies were
consistent with earlier reports of attenuation of OA accumulation by
isolated mammalian plexus with inhibition of
Na+-K+-ATPase by ouabain (8, 11,
12). Ouabain also markedly reduced active absorption of 2,4-D by
shark IV CP, as well as cellular and ECS accumulation of FL by lateral
CP, suggesting energetic coupling of OA absorption to Na+
pump activity. Ouabain inhibition of apical transport would be expected
if OA transport were coupled to that of Na+. However,
inhibition of Na+-K+-ATPase would also
depolarize membrane potential and, thus, could affect apical uptake and
basolateral efflux. Indeed, the ouabain-induced decrease in 2,4-D
absorption was accompanied by complete elimination of transepithelial
PD and ISC (Table 1) (17) and,
thus, may have involved reduced efflux of substrate, as well as
decreased apical uptake. Additional experiments are needed to define
the forces driving OA transport at each membrane of the shark CP epithelium.
Perspectives
The CP and the BBB regulate the fluid environment of the vertebrate CNS. If the in vitro data on OA transport by CP shown here reflect in vivo activity, the removal of potentially harmful OAs from the neuronal environment may be profoundly influenced by the levels of other, competing, OAs. As evidenced above, the dwell time of an endogenous neurotransmitter metabolite in CSF could be considerably extended by exposure to herbicides. From studies of CSF composition and the movement of fluid and solutes between blood and CSF, a picture of the overall function of the CP is forming. However, the picture is blurred by the lack of mechanistic and molecular detail, especially with respect to function of the intact tissue. For example, recent studies have demonstrated that CP expresses multiple OA transporters, including, oats, oatps, and mrps (10, 21, 23, 29). In some cases, transporters have been localized to a specific pole of the epithelium. Yet, for any given substrate, we do not know the complete sequence of events that results in absorption from CSF to blood. One limitation of conventional systems for the study of function in intact CP is the lack of access to the basolateral side of the tissue; another is the inability to study transport under biophysically defined conditions. Use of a comparative model, the shark, which permits confocal imaging of steps in transport combined with studies of tracer fluxes under short-circuited conditions, could largely remove many of these limitations and sharpen the picture. Of course, additional studies are needed to further explore similarities and differences in CP function and molecular biology between shark and other species. However, the initial results presented here are encouraging.| |
ACKNOWLEDGEMENTS |
|---|
This work was funded in part by National Science Foundation Grants IBN980616, IBN0078093, IBN9604070, and DBI-9820400 and National Institutes of Health Grants NS-39452, ES-10439, P30-ES-01247, and P30-ES-03828. A. R. A. Villalobos was also supported by a New Investigator Award from Mount Desert Island Biological Laboratory.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: A. R. A. Villalobos, University of Rochester, Dept. of Environmental Medicine, 575 Elmwood Ave., Box EHSC, Rochester, NY 14642 (E-mail: alice_villalobos{at}urmc.rochester.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published January 17, 2002;10.1152/ajpregu.00677.2001
Received 12 November 2001; accepted in final form 9 January 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Breen C, Sykes D, Fricker G, and Miller D. Confocal imaging of
organic anion transport in intact rat choroid plexus. Am J
Physiol Renal Physiol. In press.
2.
Bresler, SE,
Bresler VM,
Kazbekov EN,
Nikiforov AA,
and
Vasilieva NN.
On the active transport of organic acids (fluorescein) in the choroid plexus of the rabbit.
Biochim Biophys Acta
550:
110-119,
1979.
3.
Cserr, HF.
Physiology of the choroid plexus.
Physiol Rev
51:
273-311,
1971.
4.
Cserr, HF,
Bundgaard M,
Ashby J,
and
Murray M.
On the anatomic relation of choroid plexus to brain: a comparative study.
Am J Physiol Regulatory Integrative Comp Physiol
238:
R76-R81,
1980.
5.
Cserr, HF,
and
VanDyke DH.
5-Hydroxyindoleacetic acid accumulation by isolated choroid plexus.
Am J Physiol
220:
718-723,
1971.
6.
Ehrlich, BE,
and
Wright EM.
Choline and PAH transport across blood-CSF barriers: the effect of lithium.
Brain Res
250:
245-249,
1982.
7.
Fishman, RA.
Blood-brain and CSF barriers to penicillin and related organic acids.
Arch Neurol
15:
113-124,
1966.
8.
Forn, J.
Active transport of 5-hydroxyindoleacetic acid by the rabbit choroid plexus in vitro. Blockade by probenecid and metabolic inhibitors.
Biochem Pharmacol
21:
619-624,
1972.
9.
Fukushima, T,
Hirakawa T,
Tanaka A,
and
Tomonaga M.
Choroidal epithelial cyst of the prepontine region: case report and ultrastructural study.
Neurosurgery
22:
128-133,
1988.
10.
Gao, B,
and
Meier P.
Organic anion transport across the choroid plexus.
Microsc Res Tech
52:
60-64,
2001.
11.
Kim, CS,
O'Tuama LA,
Mann JD,
and
Roe CR.
Saturable accumulation of the anionic herbicide, 2,4-dichlorophenoxyacetic acid (2,4-D), by rabbit choroid plexus: early developmental origin and interaction with salicylates.
J Pharmacol Exp Ther
225:
699-704,
1983.
12.
Kim, CS,
and
Pritchard JB.
Transport of 2,4,5-trichlorophenoxyacetic acid across the blood-cerebrospinal fluid barrier of the rabbit.
J Pharmacol Exp Ther
267:
751-757,
1993.
13.
Kim, CS,
Roe CR,
Mann JD,
and
Breese GR.
Octanoic acid produces accumulation of monoamine acidic metabolites in the brain: interaction with organic anion transport at the choroid plexus.
J Neurochem
58:
1499-1503,
1992.
14.
Lorenzo, AV,
and
Spector R.
Transport of salicylic acid by the choroid plexus in vitro.
J Pharmacol Exp Ther
184:
465-471,
1973.
15.
McNutt, SN.
A thin-section and freeze fracture study of microfilament-membrane attachments in choroid plexus and intestinal microvilli.
J Cell Biol
79:
774-787,
1978.
16.
Pappenheimer, JR,
Heisey SR,
and
Jordan EF.
Active transport of Diodrast and phenolsulfonphthalein from cerebrospinal fluid to blood.
Am J Physiol
200:
1-10,
1961.
17.
Patlak, CS,
Adamson RH,
Oppelt WW,
and
Rall DP.
Potential differences of the ventricular fluid in vivo and in vitro in the dogfish.
Life Sci
5:
2011-2015,
1966.
18.
Pollay, M,
and
Davson H.
The passage of certain substances out of the cerebrospinal fluid.
Brain
86:
137-150,
1963.
19.
Pritchard, JB.
Accumulation of anionic pesticides by rabbit choroid plexus in vitro.
J Pharmacol Exp Ther
212:
354-359,
1980.
20.
Pritchard, JB,
and
Miller DS.
Mechanisms mediating renal secretion of organic anions and cations.
Physiol Rev
73:
765-796,
1993.
21.
Pritchard, JB,
Sweet DH,
Miller DS,
and
Walden R.
Mechanism of organic anion transport across the apical membrane of choroid plexus.
J Biol Chem
274:
33382-33387,
1999.
22.
Rall, DP,
and
Sheldon W.
Transport of organic acid dyes by the isolated choroid plexus of the spiny dogfish S. acanthias.
Biochem Pharmacol
11:
169-170,
1962.
23.
Rao, V,
Dahlheimer J,
Bardgett M,
Snyder A,
Finch R,
Sartorelli A,
and
Piwnica-Worms D.
Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribution to the blood-cerebrospinal fluid drug-permeability barrier.
Proc Natl Acad Sci USA
30:
3900-3905,
1999.
24.
Ruchoux, MM,
Rosati C,
Gelot A,
Lhuintre Y,
and
Garay R.
Ultrastructural study of the choroid plexus of spontaneously hypertensive rats.
Am J Hypertens
5:
851-856,
1992.
25.
Segal, MB.
Homeostasis of the CNS: transport of nutrients across the choroid plexus.
Microsc Res Tech
52:
38-48,
2001.
26.
Spector, R,
and
Johanson CE.
The mammalian choroid plexus.
Sci Am
261:
68-74,
1989.
27.
Spector, R,
and
Lorenzo AV.
Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria.
J Clin Invest
54:
316-325,
1974.
28.
Suzuki, H,
Sawada Y,
Sugiyama Y,
Iga T,
and
Hanano M.
Transport of benzyl-penicillin by the rat choroid plexus in vitro.
J Pharmacol Exp Ther
242:
660-665,
1987.
29.
Sweet, DH,
Wolff NA,
and
Pritchard JB.
Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney.
J Biol Chem
272:
30088-30095,
1997.
30.
Villalobos, AR,
Dunnick CA,
and
Pritchard JB.
Mechanism mediating basolateral transport of 2,4-dichlorophenoxyacetic acid in rat kidney.
J Pharmacol Exp Ther
278:
582-589,
1996.
31.
Zheng, W.
Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.
Microsc Res Tech
52:
89-103,
2001.
This article has been cited by other articles:
![]() |
V. Reichel, D. S. Miller, and G. Fricker Texas Red transport across rat and dogfish shark (Squalus acanthias) choroid plexus Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1311 - R1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. A. Villalobos and J. L. Renfro Trimethylamine oxide suppresses stress-induced alteration of organic anion transport in choroid plexus J. Exp. Biol., February 1, 2007; 210(3): 541 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Baehr, G. Fricker, and D. S. Miller Fluorescein-methotrexate transport in dogfish shark (Squalus acanthias) choroid plexus Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R464 - R472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Pritchard Comparative models and biological stress Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R807 - R809. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |